Ami Brannon, Chief Executive Officer

Professional Overview

Ami Brannon is an accomplished healthcare executive with extensive experience in cardiovascular services and clinical operations. As the Chief Executive Officer of Neuvana, LLC, she leverages her deep industry expertise and strategic vision to drive the company's growth and innovation. Brannon's versatile background spans clinical management, revenue generation, and executive leadership, positioning her as a valuable asset in the medical technology sector.

Experience Summary

Current Role

As the Chief Executive Officer of Neuvana, LLC, Brannon is responsible for leading the company's strategic direction, overseeing day-to-day operations, and spearheading the development and commercialization of its innovative neuromodulation technology. Under her leadership, Neuvana has expanded its market presence and solidified its position as a trailblazer in the field of neuroscience-based wellness solutions.

Career Progression

Prior to her current role, Brannon served as the Co-Founder and Board Member of Neuvana, LLC, where she played a pivotal role in the company's inception and early growth. She also held the position of Chief Revenue Officer, leveraging her expertise in revenue generation and business development to drive the company's commercial success. Additionally, Brannon's previous experience includes serving as the Clinical Admissions Manager at Trustbridge and the Administrative Director of Cardiovascular Services at Delray Medical Center, where she demonstrated her exceptional leadership and operational acumen.

Academic Background

Brannon holds a Bachelor of Science in Nursing from the University of Central Florida and a Bachelor of Science in Psychology, also from the University of Central Florida. Her diverse educational background has equipped her with a well-rounded understanding of the healthcare industry and the evolving needs of patients and providers.

Areas of Expertise

Brannon's areas of expertise include healthcare operations, revenue management, clinical admissions, and cardiovascular services. Her proven track record in leading cross-functional teams, implementing strategic initiatives, and driving revenue growth has made her a valuable asset in the medical technology sector.

Professional Impact

Throughout her career, Brannon has been recognized for her contributions to the healthcare industry. As the Chief Executive Officer of Neuvana, LLC, she has spearheaded the development and commercialization of innovative neuromodulation technology, expanding the company's market presence and solidifying its position as a leader in the field of neuroscience-based wellness solutions.

Conclusion

Ami Brannon's extensive experience, strategic acumen, and unwavering commitment to innovation make her a highly sought-after leader in the healthcare industry. As the Chief Executive Officer of Neuvana, LLC, she continues to drive the company's growth and impact, positioning it as a trailblazer in the rapidly evolving medical technology landscape.